Major advance in understanding risky but effective multiple sclerosis treatment

Powerful treatment improves patients' lives and provides new insight into mechanisms of the disease

2013-03-26

(Press-News.org) A new study by Multiple Sclerosis researchers at three leading Canadian centres addresses why bone marrow transplantation (BMT) has positive results in patients with particularly aggressive forms of MS. The transplantation treatment, which is performed as part of a clinical trial and carries potentially serious risks, virtually stops all new relapsing activity as observed upon clinical examination and brain MRI scans. The study reveals how the immune system changes as a result of the transplantation. Specifically, a sub-set of T cells in the immune system known as Th17 cells, have a substantially diminished function following the treatment. The finding to be published in the upcoming issue of Annals of Neurology and currently in the early online version, provides important insight into how and why BMT treatment works as well as how relapses may develop in MS.

"Our study examined why patients essentially stop having relapses and new brain lesions after the bone marrow transplant treatment, which involves ablative chemotherapy followed by stem cell transplantation using the patient's own cells," said Prof. Amit Bar-Or, the principle investigator of the study, who is a neurologist and MS researcher at The Montreal Neurological Institute and Hospital -The Neuro, McGill University, and Director of The Neuro's Experimental Therapeutics Program. "We discovered differences between the immune responses of these patients before and after treatment, which point to a particular type of immune response as the potential perpetrator of relapses in MS."

"Although the immune system that re-emerges in these patients from their stem cells is generally intact, we identified a selectively diminished capacity of their Th17 immune responses following therapy - which could explain the lack of new MS disease activity. In untreated patients, these Th17 cells may be particularly important in breaching the blood-brain-barrier, which normally protects the central nervous system. This interaction of Th17 cells with the blood-brain barrier can facilitate subsequent invasion of other immune cells such as Th1 cells, which are thought to also contribute to brain cell injury.

Twenty-four patients participated in the overall clinical trial as part of the 'Canadian MS BMT' clinical trial, coordinated by Drs. Mark Freedman and Harry Atkins at the Ottawa General Hospital. The new discovery, made in a subset of patients participating in the clinical trial, was based on immunological studies carried out jointly in laboratories at The Neuro and the Université de Montréal. Results of this study not only show the clinical benefits of BMT treatment, but also open a unique window into the immunological mechanisms underlying relapses in MS. Th17 cells could be the immune cells associated with the initiation of new relapsing disease activity in this group of patients with aggressive MS. This finding deepens our understanding of MS and could guide the development of personalized medicine with a more favourable risk/benefit profile.

Among the patients treated in the Canadian MS BMT clinical trial, was Dr. Alexander Normandin, a family doctor, who was a third- year McGill medical student getting ready for his surgery exams when he first learned he had MS, "I was so engrossed in my studies that I didn't pay attention to the first sign but within a few days of waking up with a numb temple, my face felt frozen. I learned that I had a very aggressive form of MS and would probably be in a wheelchair within a year. It was a brutal blow. I became patient #19 – of only 24 for this experimental treatment. My immune system was knocked out and then rebooted with my stem cells. Today, my MS has stabilized. I now have this disease under control and I take it one day at a time."

### Both the clinical and biological studies were supported by the Research Foundation of the Multiple Sclerosis Society of Canada. Link to study: http://onlinelibrary.wiley.com/doi/10.1002/ana.23784/abstract

Multiple Sclerosis MS is a disorder of the brain and spinal cord that causes fatigue, disequilibrium, sensory problems and muscle paralysis. The cause of MS is unknown, but evidence suggests that it is an auto-immune disease that destroys myelin, a substance coating axons, the thin strands that carry signals between brain cells. It usually strikes between the ages of 15 and 40 but can begin as early as age two. Women have twice the probability of developing MS than men. Canada has one of the world's highest national rates - about 1,100 new cases each year. Some 50,000 Canadians have MS. More than 1 in 5 lives in Quebec. The most common form of MS is relapsing-remitting, in which acute symptoms alternate with periods of remission. Primary progressive MS, the least common form, develops continually without remission. Secondary progressive MS begins as relapsing-remitting, then becomes steadily progressive.

The Neuro The Montreal Neurological Institute and Hospital — The Neuro, is a unique academic medical centre dedicated to neuroscience. Founded in 1934 by the renowned Dr. Wilder Penfield, The Neuro is recognized internationally for integrating research, compassionate patient care and advanced training, all key to advances in science and medicine. The Neuro is a research and teaching institute of McGill University and forms the basis for the Neuroscience Mission of the McGill University Health Centre. Neuro researchers are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of epilepsy, multiple sclerosis and neuromuscular disorders. For more information, visit theneuro.com.

ELSE PRESS RELEASES FROM THIS DATE:

Endangered lemurs' genomes sequenced

2013-03-26

For the first time, the complete genomes of three populations of aye-ayes--a type of lemur--have been sequenced and analyzed. The results of the genome-sequence analyses are published this week in the journal Proceedings of the National Academy of Sciences (PNAS). The research was led by George Perry, an anthropologist and biologist at Penn State University; Webb Miller, a biologist and computer scientist and engineer at Penn State; and Edward Louis of the Henry Doorly Zoo and Aquarium in Omaha, Neb., and Director of the Madagascar Biodiversity Partnership. The aye-aye--a ...

Researchers find novel mechanism regulating replication of insulin-producing beta cells

2013-03-26

Bringing scientists a step closer to new treatments for diabetes, researchers at the University of Pittsburgh School of Medicine and The Mount Sinai Medical Center have discovered a novel mechanism that regulates the replication of insulin-producing beta cells in the pancreas. The findings were recently published online ahead of print in Diabetes, a journal of the American Diabetes Association. Regenerating beta cells to restore insulin production has moved to center stage in the quest for therapies for both Type 1 and 2 diabetes, said lead author Nathalie Fiaschi-Taesch, ...

Vitamin D may lower diabetes risk in obese children and adolescents, MU study finds

2013-03-26

COLUMBIA, Mo. – Childhood and adolescent obesity rates in the United States have increased dramatically in the past three decades. Being obese puts individuals at greater risk for developing Type 2 diabetes, a disease in which individuals have too much sugar in their blood. Now, University of Missouri researchers found vitamin D supplements can help obese children and teens control their blood-sugar levels, which may help them stave off the disease. "By increasing vitamin D intake alone, we got a response that was nearly as powerful as what we have seen using a prescription ...

People with depression may not reap full benefits of healthy behaviors

2013-03-26

DURHAM, N.C. -- Depression may inhibit the anti-inflammatory effects typically associated with physical activity and light-to-moderate alcohol consumption, according to researchers at Duke Medicine. The finding – based on measurements of the cardio-metabolic risk marker C-reactive protein (CRP) – points to another potential danger of depression, which afflicts an estimated one in 10 adults in the United States. Study results were published online March 26, 2013, in the journal Brain, Behavior, and Immunity. "Our findings suggest depression not only directly affects ...

Sexual agreements among gay couples show promise for HIV prevention

2013-03-26

ANN ARBOR—The majority of gay men in relationships say they establish a "sexual agreement" with their partner, primarily to prevent the spread of HIV and other sexually transmitted diseases, according to a University of Michigan study. Sexual agreements show promise for HIV prevention, but the down side is that only 57 percent of couples actually concur that they have agreements, says Jason Mitchell, assistant professor at the U-M School of Nursing. Further, among nearly half of the couples one or both men break their agreement, which outlines allowable sex-related behaviors ...

Details of gene pathways suggest fine-tuning drugs for child brain tumors

2013-03-26

Pediatric researchers, investigating the biology of brain tumors in children, are finding that crucial differences in how the same gene is mutated may call for different treatments. A new study offers glimpses into how scientists will be using the ongoing flood of gene-sequencing data to customize treatments based on very specific mutations in a child's tumor. "By better understanding the basic biology of these tumors, such as how particular mutations in the same gene may respond differently to targeted drugs, we are moving closer to personalized medicine for children ...

Restaurant service linked to customer demographics, race, Wayne State research finds

2013-03-26

DETROIT — Restaurant servers are more likely to give better service to patron types they believe are more inclined to tip well, a Wayne State University researcher has found, a principle that has significant consequences when African-Americans are at the table. In an effort to determine whether servers based their service levels on perceived tipping differences across customer demographics, Zachary Brewster, Ph.D., assistant professor of sociology in the College of Liberal Arts and Sciences, analyzed data derived from a survey of 200 servers in 18 restaurants in a southeastern ...

Brief mindfulness training may boost test scores, working memory

2013-03-26

Mindfulness training may help to boost standardized test scores and improve working memory, according to a new study in Psychological Science, a journal of the Association for Psychological Science. Every year, millions of college and graduate-school applicants take standardized tests, such as the SAT and GRE. The tests supposedly provide a way to gauge students' cognitive abilities and predict how they'll perform in school and, eventually, the workplace. A multibillion-dollar test-prep industry has emerged out of the idea that boosting performance on these tests is ...

Astronomers discover new kind of supernova

2013-03-26

Pasadena, CA— Supernovae were always thought to occur in two main varieties. But a team of astronomers including Carnegie's Wendy Freedman, Mark Phillips and Eric Persson is reporting the discovery of a new type of supernova called Type Iax. This research has been accepted for publication in The Astrophysical Journal and is available online. Previously, supernovae were divided into either core-collapse or Type Ia categories. Core-collapse supernovae are the explosion of a star about 10 to 100 times as massive as our sun. Type Ia supernovae are the complete disruption ...

Regulation recommendations so that biofuel plants don't become weeds

2013-03-26

URBANA – In the United States, only species listed on state or federal noxious weed lists are regulated, and those lists are often biased toward species that affect agricultural crops. Conversely, invasive plant council lists include species that affect natural landscapes but have no regulatory clout. After comparing the lists and how they are created, researchers at the University of Illinois's Energy Biosciences Institute have developed some suggestions on how to improve the regulation of all invasive plant species, including new biofuels plants. "We're hoping to reform ...